THQM — Tchaikapharma High Quality Medicines AD Balance Sheet
0.000.00%
Last trade - 00:00- BGN1.70bn
- BGN1.71bn
- BGN53.27m
Annual balance sheet for Tchaikapharma High Quality Medicines AD, fiscal year end - December 31st, BGN millions except per share, conversion factor applied.
2020 December 31st | C2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Cash | |||||
| Cash and Equivalents | |||||
| Short Term Investments | |||||
| Cash and Short Term Investments | 0.046 | 0.057 | 0.142 | 0.073 | 0.14 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 60 | 57.5 | 58.8 | 60.2 | 64.7 |
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Current Assets | 71 | 70.7 | 75.7 | 80.9 | 87 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 37.1 | 38.1 | 35.3 | 33.1 | 33.3 |
| Net Intangible Assets | |||||
| Long Term Investments | |||||
| Long Term Notes Receivable | |||||
| Total Assets | 117 | 117 | 120 | 122 | 128 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 17.1 | 15.7 | 15.6 | 15.3 | 16.9 |
| Long Term Debt | |||||
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Deferred Income Tax | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 20.2 | 18.6 | 18.3 | 17.5 | 19.1 |
| Common Stock | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Unrealized Gain / Loss | |||||
| Total Equity | 97.1 | 98.8 | 102 | 105 | 109 |
| Total Liabilities & Shareholders' Equity | 117 | 117 | 120 | 122 | 128 |
| Total Common Shares Outstanding |